Philips Unveils Verida: First AI-Powered Detector-Based Spectral CT at RSNA 2025

At RSNA 2025, Philips introduced Verida, its next-generation detector-based spectral CT system and the first of its kind to be fully powered by artificial intelligence. This new platform builds on over a decade of clinical spectral CT innovation from Philips, now enhanced with AI across every phase of the imaging chain—from acquisition to reconstruction—to deliver faster, sharper, and more efficient results.

Verida incorporates Philips’ dual-layer detector technology, Spectral Precise Image reconstruction engine, and a new AI architecture designed to lower system noise, enhance image clarity, and reduce radiation dose and energy use without compromising quality. With the addition of AI, Philips says Verida can reduce energy consumption by up to 45% and provide dramatic dose reductions while maintaining superior image performance.

“Combining the latest advances in our proven spectral CT technology with AI, our flagship Verida CT system is designed to set a new standard in superior image quality and accelerated scans which are fully embedded in the radiology workflow, all to help clinicians detect and characterize disease earlier, reduce variability in diagnoses, and support efficient treatment pathways—in a single scan,” said Dan Xu, Business Leader of CT at Philips.

Philips’ spectral CT has already seen widespread clinical adoption, with more than 800 systems installed globally and over 800 supporting peer-reviewed studies. Verida continues this legacy while pushing new frontiers: it can reconstruct 145 images per second, generating complete spectral exams in under 30 seconds—twice as fast as previous systems. The streamlined design supports up to 270 exams per day.

Spectral CT offers a distinct clinical advantage by capturing multiple energy levels simultaneously, allowing clinicians to distinguish between tissues that look identical on conventional CT scans. This makes it especially powerful in complex applications like cardiovascular imaging, oncology, and emergency care.

“The clinical benefits of Verida will fundamentally change my approach to cardiac imaging,” said Prof. Eliseo Vañó Galván, cardiovascular radiologist and Chairman of the CT & MR Department at Hospital Nuestra. Sra. Del Rosario in Madrid, Spain. “With more comprehensive insights in every cardiac CT, I plan to make spectral imaging routine for all patients—building toward a fully spectral CT department. We evaluated many systems, including photon-counting CT, but chose Philips because it delivers the precision we need in a streamlined, easy-to-use platform.”

According to Philips, Verida is designed not just for clinical excellence, but also for operational efficiency. AI-powered tools reduce the need for repeat exams and integrate seamlessly into PACS workflows, offering radiology teams faster turnaround, more consistent results, and greater diagnostic confidence. Unlike photon-counting CT, which remains largely in the research phase, Philips’ spectral CT has already proven itself in routine care—and Verida represents the next leap forward.

The new platform will be available in select markets beginning in 2026.